The Asia-Pacific genomic biomarker market is estimated to grow significantly at a CAGR of over 16% during the forecast period. Asia-Pacific is both a strong and promising market for genomic biomarkers market. This is particularly due to the strong population base, high prevalence of chronic diseases such as cancer and CVDs in Asian countries such as China, Japan, and India. China has a strong market for genomic biomarkers due to huge government investments in R&D and life science ... Read more